Clinical Trials Directory

Trials / Completed

CompletedNCT00955461

Comparison of the RevLite Electro-optic Q-Switched Neodymium-doped Yttrium Aluminium Garnet (EO QS Nd:YAG) Laser to a Fractionated Laser System

Post-Market, Randomized, Single Blind, Split-Faced Comparison of the RevLite Nd:YAG Laser System Versus a Non-Ablative, Mid Infra-red, Fractionated Type Laser System for Skin Rejuvenation

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
12 (actual)
Sponsor
ConBio, a Cynosure Company · Industry
Sex
All
Age
25 Years – 65 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to compare the results of treatment between the side of the face treated with the RevLite Laser and the side of the face treated with a fractionated laser system.

Conditions

Interventions

TypeNameDescription
PROCEDURERevLite laser treatmentElectro-optic Q-Switched Nd: YAG Laser treatment
PROCEDUREFractionated Laser treatment

Timeline

Start date
2009-12-01
Primary completion
2012-02-01
Completion
2012-02-01
First posted
2009-08-10
Last updated
2012-11-28

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00955461. Inclusion in this directory is not an endorsement.

Comparison of the RevLite Electro-optic Q-Switched Neodymium-doped Yttrium Aluminium Garnet (EO QS Nd:YAG) Laser to a Fr (NCT00955461) · Clinical Trials Directory